- Home
- RNAC vs NEWT Comparison
RNAC vs NEWT Comparison
Compare RNAC & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- NEWT
- Stock Information
- Founded
- RNAC 2007
- NEWT 1998
- Country
- RNAC United States
- NEWT United States
- Employees
- RNAC N/A
- NEWT N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- RNAC Health Care
- NEWT Finance
- Exchange
- RNAC Nasdaq
- NEWT Nasdaq
- Market Cap
- RNAC 276.3M
- NEWT 294.8M
- IPO Year
- RNAC 2016
- NEWT N/A
- Fundamental
- Price
- RNAC $10.05
- NEWT $12.37
- Analyst Decision
- RNAC Strong Buy
- NEWT Hold
- Analyst Count
- RNAC 4
- NEWT 4
- Target Price
- RNAC $40.00
- NEWT $13.00
- AVG Volume (30 Days)
- RNAC 48.4K
- NEWT 188.9K
- Earning Date
- RNAC 08-07-2025
- NEWT 07-28-2025
- Dividend Yield
- RNAC N/A
- NEWT 6.14%
- EPS Growth
- RNAC N/A
- NEWT 21.23
- EPS
- RNAC N/A
- NEWT 2.01
- Revenue
- RNAC $1,026,000.00
- NEWT $364,004,000.00
- Revenue This Year
- RNAC N/A
- NEWT N/A
- Revenue Next Year
- RNAC N/A
- NEWT $12.73
- P/E Ratio
- RNAC N/A
- NEWT $6.15
- Revenue Growth
- RNAC N/A
- NEWT 20.91
- 52 Week Low
- RNAC $8.46
- NEWT $9.12
- 52 Week High
- RNAC $26.50
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- RNAC 34.71
- NEWT 61.20
- Support Level
- RNAC $10.50
- NEWT $12.16
- Resistance Level
- RNAC $11.80
- NEWT $12.48
- Average True Range (ATR)
- RNAC 0.56
- NEWT 0.27
- MACD
- RNAC -0.11
- NEWT 0.02
- Stochastic Oscillator
- RNAC 0.45
- NEWT 73.00
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.